SANDY SPRINGS, Ga., Feb. 20, 2020 /PRNewswire/ -- Pyramid Family Behavioral Healthcare announced today it plans to open a second adult and adolescent intensive mental health outpatient and partial hospitalization behavioral health treatment program in Sandy Springs, Georgia in March 2020.Pyramid F

BOSTON, Feb. 20, 2020 /PRNewswire/ -- In response to the growing impact of severe storms and flooding in several Southern U.S. states, Blue Cross Blue Shield of Massachusetts ("Blue Cross") is expanding its offer of expedited access to care to members in Mississippi and

LA CROSSE, Wis., Feb. 20, 2020 /PRNewswire/ -- The country's most established program for Advance Care Planning (ACP) practice and capacity building, Respecting Choices guides organizations and communities worldwide to effectively implement and sustain evidence-based systems that provide person-centered care."We're honored to be the first advance care planning pro

SALT LAKE CITY, Feb. 20, 2020 /PRNewswire/ -- ARUP Laboratories announced today that the Food and Drug Administration (FDA) has filed ARUP's premarket approval application (PMA) for an AAV5 total antibody assay. The assay is intended as a companion diagnostic test for valoctocogene roxaparvovec, BioMarin's investigational gene therapy treatment for severe hemophilia

MECHANICSBURG, Pa., Feb. 20, 2020 /PRNewswire/ --  Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2019.For the fourth quarter ended December 31, 2019, net operating revenues increased 8.7% to $1,374.6 million, compared to

COLUMBUS, Ga., Feb. 20, 2020 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will present at the Credit Suisse 21st Annual Financial Services Forum. Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos will represent the company with a presentation on February 27, 2020

WASHINGTON, Feb. 20, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on April 24, 2020 to holders of record on March 27, 2020. In addition,

ROCKVILLE, Md., Feb. 20, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to deve

SANTA CLARA, Calif., Feb. 20, 2020 /PRNewswire/ --Fourth Quarter 2019 OverviewRevenue for the fourth quarter of 2019 was $301.7 million, a 124% increase compared to $134.9 million for the fourth quarter of 2018. GAAP net income for the fourth quarter of 2019

NEW YORK, Feb. 20, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Acceleron Pharma Inc. (NASDAQ: XLRN). If you are a shareholder of Acceleron Pharma Inc. and are interested in obtaining